Author:
Tasong Loïc Alban Mbosso,Nganou-Gnindjio CN,Yemele Honoré Kemnang,Elong Jules Thierry,Kuate Laura Murielle Makowa,Kuissu Simeon,Menanga Alain Patrick
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498.
2. Boombhi J, Menanga A, Mfeukeu-Kuate L, Kungni E, Mounpou B, Kingue S. Caractéristiques Cliniques et Thérapeutiques de la Fibrillation atriale en Milieu Hospitalier à Yaoundé. Halth Sci Dis. 2019;20(5).
3. Sani MU, Davison BA, Cotter G, Mayosi BM, Edwards C, Ogah OS, et al. Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry. Cardiovasc J Afr. 2018;29(3):139–45.
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.
5. Hersi AS, Alsheikh-Ali AA, Zubaid M, Suwaidi JA. Prospective observational studies of the management and outcomes in patients with atrial fibrillation: a systematic review. J Saudi Heart Assoc. 2012;24(4):243–52.